Moderna

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Moderna and other ETFs, options, and stocks.

About MRNA

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid (mRNA). Its product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics. 

CEO
Stéphane Bancel
CEOStéphane Bancel
Employees
5,600
Employees5,600
Headquarters
Cambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded
2010
Founded2010
Employees
5,600
Employees5,600

MRNA Key Statistics

Market cap
42.05B
Market cap42.05B
Price-Earnings ratio
-8.59
Price-Earnings ratio-8.59
Dividend yield
Dividend yield
Average volume
3.65M
Average volume3.65M
High today
$112.00
High today$112.00
Low today
$105.95
Low today$105.95
Open price
$111.11
Open price$111.11
Volume
3.96M
Volume3.96M
52 Week high
$163.24
52 Week high$163.24
52 Week low
$62.55
52 Week low$62.55

MRNA News

Yahoo Finance 10h
Moderna Posts Pipeline Progress, Secures Blackstone Funding - Yahoo Finance

Shares of Moderna MRNA rose 3% on Wednesday after management announced positive clinical updates at its Vaccines Day Event, highlighting its pipeline progress....

Moderna Posts Pipeline Progress, Secures Blackstone Funding - Yahoo Finance
Yahoo Finance 1d
Moderna Posts Upbeat Data From Next-Gen COVID Jab Study - Yahoo Finance

Moderna MRNA announced positive results from the pivotal phase III NextCOVE study evaluating mRNA-1283, its next-generation refrigerator-stable COVID-19 vaccine...

Moderna Posts Upbeat Data From Next-Gen COVID Jab Study - Yahoo Finance
Yahoo Finance 1d
Moderna CEO discusses China investment, expanding vaccines - Yahoo Finance

Moderna (MRNA) is advancing three of its vaccines into Phase Three trials as the pharmaceutical giant hopes to expand its product pipeline past its COVID-19 vac...

Moderna CEO discusses China investment, expanding vaccines - Yahoo Finance

Analyst ratings

50%

of 26 ratings
Buy
50%
Hold
38.5%
Sell
11.5%

More MRNA News

TipRanks 1d
Moderna Unveils Vaccine Pipeline Beyond COVID-19

Moderna (NASDAQ:MRNA) gave some key updates regarding its pipeline ahead of its Vaccine Day event and made it clear that the biotech company has more to offer b...

Benzinga 2d
What's Going On With Moderna Stock Wednesday?

Loading... Loading... Moderna Inc MRNA shares are trading higher Wednesday after the company announced that MRNA-1283 met the primary endpoints in its Phase 3...

What's Going On With Moderna Stock Wednesday?
TipRanks 2d
Blackstone to provide up to $750M to fund Moderna’s influenza program

Blackstone (BX) announced a new collaboration with Moderna (MRNA) through a development and commercialization funding agreement where funds managed by Blackston...

Yahoo Finance 2d
Blackstone Life Sciences Announces Collaboration to Support Moderna's Influenza Program - Yahoo Finance

Blackstone Life Sciences to invest up to $750 million to support innovative mRNA technology NEW YORK, March 27, 2024--(BUSINESS WIRE)--Blackstone (NYSE:BX) ann...

Blackstone Life Sciences Announces Collaboration to Support Moderna's Influenza Program - Yahoo Finance
Yahoo Finance 2d
Moderna Advances Multiple Vaccine Programs to Late-Stage Clinical Trials - Yahoo Finance

Announces next-generation COVID-19 vaccine candidate as fourth respiratory vaccine to successfully meet its Phase 3 endpoints Expects two more Phase 3 readouts...

Moderna Advances Multiple Vaccine Programs to Late-Stage Clinical Trials - Yahoo Finance
Benzinga 2d
Cathie Wood's Ark Invest Continues To Double Down On Moderna, Sells Nvidia Shares

Loading... Loading... On Tuesday, Cathie Wood’s Ark Invest made a significant move by increasing its stake in Moderna Inc. MRNA, a leading COVID-19 vaccine mak...

Cathie Wood's Ark Invest Continues To Double Down On Moderna, Sells Nvidia Shares
Benzinga 2d
Moderna's Next Gen COVID Vaccine Meets Primary Goal In Late-Stage Trial

Loading... Loading... Tuesday, Moderna Inc MRNA said that mRNA-1283, the company’s next-generation COVID-19 vaccine, has met the primary endpoints of its Phase...

Moderna's Next Gen COVID Vaccine Meets Primary Goal In Late-Stage Trial
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.